Xenetic Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Xenetic Biosciences

12/05/2021 17:07

* Xenetic Biosciences Inc  XBIO.OQ  reported a quarterly
adjusted loss of 15 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was for a
loss of 13 cents per share.
* Revenue rose 235.1% to $191.00 thousand from a year ago; 
analysts expected $60.00 thousand. 
* Xenetic Biosciences Inc's reported EPS for the quarter was a
loss of 15 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Xenetic Biosciences Inc shares had fallen by 17.9% this
quarter and lost 12.3% so far this year.
* The company reported a quarterly loss of $1.35 million.
* Wall Street's median 12-month price target for Xenetic
Biosciences Inc is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 12 at 04:07 p.m. GMT.
​All figures in US dollars